At the news
? NEUTRALIMPACT 2/10 CLUSTER filed Jun 2, 2026 at 18:08 ET
Three C-suite officers at Neurocrine Biosciences sold a total of ~$2.73M in open-market shares within a 7-day window. All sales followed derivative exercises (non-cash M and A), and one officer (Boyer D.) sold without a prior M, which is routine compensation-driven selling. At $16.6B market cap, the cluster is ~0.016% of cap, below the 0.1% materiality floor for insider sales, rendering the cluster classificationally trivial. Per the asymmetry rule for sales (Alldredge 2019), no amplification is applied.
- Cluster: 3 C-suite officers sold ~2.73M in open-market shares over 7 days (May 26, June 2, 2026)
- Largest sale: CSO Onyia Jude sold $1.76M (11K shares at ~$160.25) after exercising options
- CRO Delaet Ingrid sold $354K; Chief Corp. Affairs Boyer D.W. sold $609K; CMO Keswani had only non-cash derivative activity
- Total open-market sales: ~$2.73M, or ~0.016% of $16.6B market cap, below the 0.1% materiality floor
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access